VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity - Concepedia

Concepedia

Publication | Open Access

VELOUR trial biomarkers update: Impact of RAS, BRAF, and sidedness on aflibercept activity

DOI Full Paper Access

39

Citations

0

References

2017

Year

Pratyaksha Wirapati, Valentina Pomella, Ben Vandenbosch, Peter Kerr, Evaristo Maiello, Mark Jeffery Grahame, Razvan-Ovidiu D. Curca, Meinolf Karthaus, John Bridgewater, Anca Mihailov,

Annals of Oncology

Biomarker (Medicine)Velour Trial BiomarkersAllergyMedicineBiomarker TargetAflibercept ActivityClinical TrialsTherapeutic EfficacyBiomarkersBiomarker DiscoveryClinical ChemistryMetabolomicsMolecular DiagnosticsPharmacologyDrug Discovery

No additional data available for this publication yet. Check back later!